Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stage IVS neuroblastoma.

J Uchino, Y Hata, Y Kasai

    Journal of Pediatric Surgery
    |April 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Stage IVS neuroblastoma in infants under 1 year has a 70% survival rate, with regressions showing cell maturation. Conservative treatment is recommended to support immune function in neuroblastoma patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
    Same author

    Streamline phenomena in liver metastasis of gastrointestinal tumor - an experimental-study using rats.

    Oncology reports·2011
    Same author

    Diagnostic-significance of liver-failure after newly-appeared serum fractions following liver surgery.

    Oncology reports·2011
    Same author

    Eyelid metastasis originated from gastric-cancer.

    Oncology reports·2011
    Same author

    Relationship between mdr-1 messenger-RNA expression and anticancer drug-sensitivity in human hepatocellular-carcinoma cell-lines.

    Oncology reports·2011
    Same author

    Effects of tnp-470 (agm-1470) on tumor-growth, angiogenesis and serum copper levels in liver-cancer bearing rats.

    Oncology reports·2011
    Same journal

    Reimagining the Surgical Safety Checklist Through a Pediatric Lens.

    Journal of pediatric surgery·2026
    Same journal

    Bridge Fixation Provides Consistent Implant Stability Across Surgical Techniques: A Multicenter Study.

    Journal of pediatric surgery·2026
    Same journal

    National Benchmarks for Penetrating Head Injury in U.S. Children and Adolescents: Mechanism, Intent, and Disparities in Mortality.

    Journal of pediatric surgery·2026
    Same journal

    Long-Term Growth and Neurodevelopmental Outcomes of a Standardized Gastroschisis Feeding Protocol: a retrospective cohort study.

    Journal of pediatric surgery·2026
    Same journal

    Economic Evaluation of Hirschsprung Disease Testing Strategies for Children with Medically-Refractory Chronic Constipation: A Cost-Effectiveness Analysis.

    Journal of pediatric surgery·2026
    Same journal

    Preoperative underweight is associated with a more complicated perioperative course and impairs recovery in Hirschsprung's disease: The pivotal role of weight-for-age z-score.

    Journal of pediatric surgery·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Immunology
    • Surgical Pathology

    Background:

    • Neuroblastoma is a common pediatric cancer.
    • Stage IVS neuroblastoma is a specific subtype with unique characteristics.
    • Understanding prognostic factors and optimal treatment is crucial for improving outcomes.

    Purpose of the Study:

    • To review findings in 10 cases of stage IVS neuroblastoma.
    • To evaluate prognostic indicators and treatment strategies.
    • To correlate patient outcomes with immunological markers.

    Main Methods:

    • Retrospective review of 10 stage IVS neuroblastoma cases.
    • Histological examination of tumor regressions.
    • Analysis of lymphocyte counts and T-cell function.

    Related Experiment Videos

  • Correlation of clinical data with survival outcomes.

    • Main Results:

    • A 70% survival rate was observed in patients under 1 year with stage IVS neuroblastoma.
    • Histological confirmation of neuroblastoma cell maturation to ganglioma cells.
    • Surviving patients maintained lymphocyte counts and T-cell function, unlike non-survivors.

    Conclusions:

    • Stage IVS neuroblastoma in young children has a favorable prognosis.
    • Tumor regression via cell maturation is a key factor in favorable outcomes.
    • Conservative management is advised to preserve immune mechanisms, with intervention reserved for disease progression or respiratory compromise.